Product
Details
Platinum
is a trace element that helps promote healthy functioning of normal
tissue. It has recently shown promise in the realm of immune system
health.*
|
Platinum
Helps to Support:
|
| ·
Healthy cellular replication* |
| ·
Healthy spine* |
| ·
Healthy muscle function* |
| ·
Mental alertness* |
| ·
Healthy nerve function* |
| ·
Healthy sleep patterns* |
| ·
Healthy sinus and facial sensations* |
Minerals for Life™ water-soluble
Platinum is a dietary supplement containing elemental platinum.
Platinum is used to promote normal cell replication. It also helps
support a healthy immune system.* Platinum is a trace element that
helps promote healthy functioning of normal tissue.*
Platinum promotes healthy ear functioning by helping the removal of
toxins from the body.* It also enables tissue metabolism for healthy
skin.*
Platinum is a trace mineral that has been suggested to help the body
in nerve and muscle function.* It has also been linked to increased
mental alertness and increased energy.* Proper platinum reserves
encourage mental health and well-being and even sobriety. Ideal
platinum levels can even promote self-preservation and a positive
outlook.
Adult Directions
Take 1 teaspoon daily with a meal. Do not exceed
1 teaspoon daily. This product may be taken on an occasional basis
as desired.
Caution
Do not consume if tamper resistant seal is broken or missing. Keep
cap tightly closed and out of reach of children. Not intended for
children under 14 years of age. Not for pregnant or lactating women.
First consult with your physician before starting this or any new
mineral or nutrient supplement program. Isolated minerals or
nutrients are best taken as part of a comprehensive supplement
program containing a broad spectrum of nutrients.
| *
This statement has not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose,
treat, cure, or prevent any disease. |
Scientific
Reference
Barakat RR. Benjamin I. Lewis JL Jr. Saigo PE. Curtin JP. Hoskins WJ.
Platinum-based chemotherapy for advanced-stage serous ovarian
carcinoma of low malignant potential. Gynecologic Oncology.
59(3):390-3, 1995 Dec.
Connors TA. Jones M. Ross WC. Braddock PD. Khokhar AR. Tobe ML. New
platinum complexes with anti-tumour activity. Chemico-Biological
Interactions. 5(6):415-24, 1972.
Farrell N. Nonclassical platinum antitumor agents: perspectives for
design and development of new drugs complementary to cisplatin.
[Review] [74 refs] Cancer Investigation. 11(5):578-89, 1993.
Leh FK. Wolf W. Platinum complexes: a new class of antineoplastic
agents. Journal of Pharmaceutical Sciences. 65(3):315-28, 1976.
Maeda M. Takasuka N. Suga T. Sasaki T. New antitumor platinum(II)
complexes with both lipophilicity and water miscibility. Japanese
Journal of Cancer Research. 81(6-7):567-9, 1990.
Maeda M. Uchida NA. Sasaki T. Liposoluble platinum(II) complexes
with antitumor activity. Japanese Journal of Cancer Research.
77(6):523-5, 1986.
Perevodchikova NI. Gorbunova VA. Grigorova TM. Kozachenko VP.
Marenich AF. [Combined chemotherapy including platinum derivatives
in the combined treatment of patients with stage-III to -IV ovarian
cancer]. [Russian] Vestnik Akademii Meditsinskikh Nauk SSSR.
(5):8-11, 1986.
Pouskouleli G. Kourounakis P. Platinum compounds in cancer
chemotherapy. Biochemistry & Experimental Biology.
16(2):191-212, 1980.
Shparyk IaV. Bilynskyi BT. [Effectiveness of platinum drugs in the
treatment of gastric cancer]. [Ukrainian] Klinicheskaia Khirurgiia.
(5):48-53, 1993.
ten Bokkel Huinink WW. Eisenhauer E. Swenerton K. Preliminary
evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel)
dose and infusion length in platinum-treated ovarian cancer.
Canadian-European Taxol Cooperative Trial Group. Cancer Treatment
Reviews. 19 Suppl C:79-86, 1993.
Waxman J. Wasan H. Platinum-based chemotherapy for bladder cancer.
Seminars in Oncology. 21(5 Suppl 12):54-60, 1994 Oct.
Williams CJ. Stewart L. Parmar M. Guthrie D. Meta-analysis of the
role of platinum compounds in advanced ovarian carcinoma. The
Advanced Ovarian Cancer Trialists Group. Seminars in Oncology. 19(1
Suppl 2):120-8, 1992.